Pertuzumab (Intravenous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Pertuzumab (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Perjeta

Description

Pertuzumab injection is used to treat breast cancer that has spread to other parts of the body. It is used together with other cancer medicines, docetaxel and trastuzumab, and only in patients with HER2-positive breast cancer. The HER2 protein is produced by some breast tumors. Pertuzumab interferes with the growth of this protein, which is eventually destroyed by the body. It is a monoclonal antibody.

This medicine is to be administered only by or under the immediate supervision of your doctor.

This product is available in the following dosage forms:

  • Solution
Before Using
DR603633 Portions of this document last updated: July 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger